Discovery Laboratories har siden 2004 søgt om FDA godkendelse på Surfaxin, et produkt som hjælper med at optage ilt i lungerne.
af hvad jeg kan finde ud af, så er det et alvorligt problem for 1 ud af 8 for tidligt fødte børn, - men også for mange andre lungesygdomme skulle der være et stort potentiale.
men som Solsen har skrevet flere gange, så er det hvis også under kategorien lørdagslotto.
i 2004 da første ansøgning blev afleveret var kursen over 10, nu handles den i 1, efter en større stigning, da mødet d. 29 sep blev offentliggjort.
http://www.discoverylabs.com/welcome.htm
af hvad jeg kan finde ud af, så er det et alvorligt problem for 1 ud af 8 for tidligt fødte børn, - men også for mange andre lungesygdomme skulle der være et stort potentiale.
men som Solsen har skrevet flere gange, så er det hvis også under kategorien lørdagslotto.
i 2004 da første ansøgning blev afleveret var kursen over 10, nu handles den i 1, efter en større stigning, da mødet d. 29 sep blev offentliggjort.
http://www.discoverylabs.com/welcome.htm
18921 lidt useriøst indlæg, men pil op for engagementet.
fandt dette, lidt sjove indlæg på et amerikansk forum.
Johnny Cash would be proud...
How high's the prices momma....she said it's .49 and risin'
How high's the prices pappa...she said it's .49 and risin...
Well I lost my ass when the prices crashed and I can't afford to even
cut the grass...how high the prices momma she said it's .49 and
risin....
How high's the prices momma...she said it's .91 and risin....
How highs's the prices pappa...she said it's .91 and risin...
Well I gotta say that if it stays this way we can finally afford that
get-a-way...how highs the prices momma, she said it's .91 and risin...
How high's the prices momma...she said it 1.03 and risin...
How high's the prices pappa...she said it's 1.03 and risin...
Well since July we've headed towards the sky, the shorts want us to
stop, but we gotta try....How highs the price momma she said it's 1.03
and risin
High high's the prices momma...She said she waitin' on approval
How high's the prices pappa...She said she waitin on approval
Well Tuesday's the day the FDA will say wether Discovery Labs can be
on it's way...How highs the prices momma...she said she's waitin on
approval...
Well she is waitin on approval.....
Thank you...I will be here till Tuesday....
fandt dette, lidt sjove indlæg på et amerikansk forum.
Johnny Cash would be proud...
How high's the prices momma....she said it's .49 and risin'
How high's the prices pappa...she said it's .49 and risin...
Well I lost my ass when the prices crashed and I can't afford to even
cut the grass...how high the prices momma she said it's .49 and
risin....
How high's the prices momma...she said it's .91 and risin....
How highs's the prices pappa...she said it's .91 and risin...
Well I gotta say that if it stays this way we can finally afford that
get-a-way...how highs the prices momma, she said it's .91 and risin...
How high's the prices momma...she said it 1.03 and risin...
How high's the prices pappa...she said it's 1.03 and risin...
Well since July we've headed towards the sky, the shorts want us to
stop, but we gotta try....How highs the price momma she said it's 1.03
and risin
High high's the prices momma...She said she waitin' on approval
How high's the prices pappa...She said she waitin on approval
Well Tuesday's the day the FDA will say wether Discovery Labs can be
on it's way...How highs the prices momma...she said she's waitin on
approval...
Well she is waitin on approval.....
Thank you...I will be here till Tuesday....
18924 har fda ikke afvist surfaxin 3-4 gange allerede ?
men held og lykke tirsdag :)
men held og lykke tirsdag :)
18929 hej
jo.. den er blevet afvist nogle gange siden 2003/4
og den bliver heller ikke godkendt tirsdag, som jeg har forstået det.
Tirsdagens møde er en opfølgning fra et møde i juni, og handler for så vidt jeg er orienteret om at FDA sætter retningslinierne for en evt. godkendelse.
jo.. den er blevet afvist nogle gange siden 2003/4
og den bliver heller ikke godkendt tirsdag, som jeg har forstået det.
Tirsdagens møde er en opfølgning fra et møde i juni, og handler for så vidt jeg er orienteret om at FDA sætter retningslinierne for en evt. godkendelse.
18963 hej
jeg er ikke så forbandet stærk i TA, nogen der kan prøve at analysere følgende, fundet på thelion.com
1. Flattened 200 DMA starting to curve up: Downtrend finished.
2. Look at the continued ascent of the 50DMA and soon to happen cross-over within days
3. Look at the healthy parabolic SARS still strong, acute upward angle
4. Look at the volume patterns.......consecutively and consistently declining in selling days
5. Look at the double bottom in the RSI
6. Look at the difficulty in achieving accumulation of shares by the buyers.....just ain't any significant pool of sellers.
This is a SHORTER's SWEATY SITUATION. They are now running on fumes only...
And they will tomorrow be fuming mad they didn't close out their position in the last 10 days when they had plenty of opportunity.
Market Manager is going to make a ton of money off the shorts
jeg er ikke så forbandet stærk i TA, nogen der kan prøve at analysere følgende, fundet på thelion.com
1. Flattened 200 DMA starting to curve up: Downtrend finished.
2. Look at the continued ascent of the 50DMA and soon to happen cross-over within days
3. Look at the healthy parabolic SARS still strong, acute upward angle
4. Look at the volume patterns.......consecutively and consistently declining in selling days
5. Look at the double bottom in the RSI
6. Look at the difficulty in achieving accumulation of shares by the buyers.....just ain't any significant pool of sellers.
This is a SHORTER's SWEATY SITUATION. They are now running on fumes only...
And they will tomorrow be fuming mad they didn't close out their position in the last 10 days when they had plenty of opportunity.
Market Manager is going to make a ton of money off the shorts
19016 Positivt FDA møde.
DSCO mener at vejen er banet for en godkendelse af Surfaxin, og forventer at kunne aflevere nye data til FDA i midten af 4. kvartal.
aktien op 40% idag i premarket på nyheden.
http://www.globenewswire.com/newsroom/news.html?d=174367
DSCO mener at vejen er banet for en godkendelse af Surfaxin, og forventer at kunne aflevere nye data til FDA i midten af 4. kvartal.
aktien op 40% idag i premarket på nyheden.
http://www.globenewswire.com/newsroom/news.html?d=174367
19109 Midtugen flotte stigning er stort set jævnet til jorden :(
berettiget mistro til Surfaxin eller Short covering?
http://www.thestreet.com/_yahoo/story/10606562/1/discovery-labs-pump-up-the-volume.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
berettiget mistro til Surfaxin eller Short covering?
http://www.thestreet.com/_yahoo/story/10606562/1/discovery-labs-pump-up-the-volume.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
19113 Midtugen flotte stigning er stort set jævnet til jorden :(
berettiget mistro til Surfaxin eller Short covering?
http://www.thestreet.com/_yahoo/story/10606562/1/discovery-labs-pump-up-the-volume.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
berettiget mistro til Surfaxin eller Short covering?
http://www.thestreet.com/_yahoo/story/10606562/1/discovery-labs-pump-up-the-volume.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
19116 ja, der var store muligheder for at trade denne aktie i ugens løb, lavede selv 50% fortjeneste, men købte mig ind igen lidt for tidligt..
-
men... ved ikke hvordan jeg skal tackle den i kommende uge, -
d. 30 september, dagen efter de positive nyheder (At FDA og DSCO planlægger næste skridt for Surfaxin, for at komme nærmere godkendelse) stiger DSCO fra 0,97 til 1,68, for derefter at komme ned og slutte ugen lige omkring 1,10.
det interessante, eller bekymrende er, at der blev handlet ca. 80% ad samtlige aktier i selskabet d 30. -og halvdelen af alle handler skete over kurs 1,40 - så jeg forventer at jeg kan lave et par gode handler i denne aktie i den kommende uge.
jeg vil ikke blive overrasket overhovedet hvis vi kommer over kurs 2 inden næste fredag. hvis der er bare 10% chance for godkendelse af Surfaxin, burde aktien ligge i min. kurs 2 nu.
Surfaxin ER en blockbuster, hvis den bliver godkendt, og DSCO har udmeldt at de kan klare de krav FDA kom med, og at de kan opfylde de første i midten af 4 kvartal.
The FDA regulatory process has led to long delays for Surfaxin. The meeting with the FDA this week focused on Discovery Labs' plans regarding optimization and final method validation of its Biological Activity Test, or BAT, and a proposed limited Surfaxin clinical trial design, which would simultaneously employ the newly optimized BAT, the company said.
-
men... ved ikke hvordan jeg skal tackle den i kommende uge, -
d. 30 september, dagen efter de positive nyheder (At FDA og DSCO planlægger næste skridt for Surfaxin, for at komme nærmere godkendelse) stiger DSCO fra 0,97 til 1,68, for derefter at komme ned og slutte ugen lige omkring 1,10.
det interessante, eller bekymrende er, at der blev handlet ca. 80% ad samtlige aktier i selskabet d 30. -og halvdelen af alle handler skete over kurs 1,40 - så jeg forventer at jeg kan lave et par gode handler i denne aktie i den kommende uge.
jeg vil ikke blive overrasket overhovedet hvis vi kommer over kurs 2 inden næste fredag. hvis der er bare 10% chance for godkendelse af Surfaxin, burde aktien ligge i min. kurs 2 nu.
Surfaxin ER en blockbuster, hvis den bliver godkendt, og DSCO har udmeldt at de kan klare de krav FDA kom med, og at de kan opfylde de første i midten af 4 kvartal.
The FDA regulatory process has led to long delays for Surfaxin. The meeting with the FDA this week focused on Discovery Labs' plans regarding optimization and final method validation of its Biological Activity Test, or BAT, and a proposed limited Surfaxin clinical trial design, which would simultaneously employ the newly optimized BAT, the company said.

